REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Biotopex" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Pipeline Transportation | Warehousing and Storage | Architectural, Engineering, and Related Services | Scientific Research and Development Services
Full name: "Biotopex" Sp. z o.o. Profile Updated: May 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Biotopex" Sp. z o.o. is an enterprise in Poland, with the main office in Lublin. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on December 17, 2015. "Biotopex" Sp. z o.o. currently employs 1 (2016) people. The latest financial highlights indicate a net sales revenue increase of 62.4% in 2023. Its’ total assets recorded a growth of 93.01%. The net profit margin of "Biotopex" Sp. z o.o. increased by 8.5% in 2023.

Headquarters
Ul. Wojciechowska 15
Lublin; Lubelskie; Postal Code: 20-704

Contact Details: Purchase the "Biotopex" Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the "Biotopex" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Biotopex" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Biotopex" Sp. z o.o. report to view the information.
Incorporation Date:
December 17, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after "Biotopex" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
62.4%▲
Total operating revenue
62.6%▲
Operating profit (EBIT)
617.51%▲
Net Profit (Loss) for the Period
512.07%▲
Total assets
93.01%▲
Total equity
127.31%▲
Operating Profit Margin (ROS)
10.37%▲
Net Profit Margin
8.5%▲
Return on Equity (ROE)
35.21%▲
Debt to Equity Ratio
-38.97%▼
Quick Ratio
0.85%▲
Cash Ratio
-0.21%▼

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Access Pharma Sp. z o.o.
 
Zeptor Polska Sp. z o.o.
Hauster Sp. z o.o. sp. k.
 
Medisfarm Sp. z o.o.
"Venus Hdh" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo